ARTICLE | Clinical News
Sinobiomed preclinical data
August 27, 2007 7:00 AM UTC
In dogs and rabbits, recombinant human kallikrein (rhK1) significantly reduced the damage to nerve function caused by ischemic brain infarction. The compound also decreased the size of the infarction...